VIVUS LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction

Phase 3
Completed
Conditions
Erectile Dysfunction
Interventions
Drug: avanafil
First Posted Date
2009-03-02
Last Posted Date
2012-08-17
Lead Sponsor
VIVUS LLC
Target Recruit Count
712
Registration Number
NCT00853606
Locations
🇺🇸

Research Site, Spring, Texas, United States

A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.

Phase 1
Completed
Conditions
Obesity
First Posted Date
2009-02-12
Last Posted Date
2010-01-21
Lead Sponsor
VIVUS LLC
Target Recruit Count
20
Registration Number
NCT00842400
Locations
🇺🇸

MDS Pharma Services, Phoenix, Arizona, United States

A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers

Phase 1
Completed
Conditions
Torsades de Pointes
Interventions
Drug: VI-0521
First Posted Date
2009-02-10
Last Posted Date
2010-01-21
Lead Sponsor
VIVUS LLC
Target Recruit Count
112
Registration Number
NCT00839891
Locations
🇺🇸

MDS Pharma Services, Phoenix, Arizona, United States

Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: ethinyl estradiol, norethindrone, VI-0521
First Posted Date
2009-01-13
Last Posted Date
2009-12-02
Lead Sponsor
VIVUS LLC
Target Recruit Count
20
Registration Number
NCT00821496
Locations
🇺🇸

MDS Pharma Services, Phoenix, Arizona, United States

Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D)

Phase 3
Completed
Conditions
Erectile Dysfunction
Interventions
Drug: placebo
Drug: avanafil
First Posted Date
2008-12-17
Last Posted Date
2012-08-17
Lead Sponsor
VIVUS LLC
Target Recruit Count
390
Registration Number
NCT00809471
Locations
🇺🇸

Research Site, Spring, Texas, United States

A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.

First Posted Date
2008-12-10
Last Posted Date
2013-09-13
Lead Sponsor
VIVUS LLC
Target Recruit Count
80
Registration Number
NCT00806260
Locations
🇺🇸

Research Site, Lincoln, Nebraska, United States

A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)

Phase 3
Completed
Conditions
Obesity
Interventions
Drug: VI-0521
Drug: Placebo
First Posted Date
2008-11-24
Last Posted Date
2012-09-10
Lead Sponsor
VIVUS LLC
Target Recruit Count
676
Registration Number
NCT00796367

Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED

Phase 3
Completed
Conditions
Erectile Dysfunction
Interventions
Drug: placebo
Drug: avanafil
First Posted Date
2008-11-13
Last Posted Date
2012-07-11
Lead Sponsor
VIVUS LLC
Target Recruit Count
646
Registration Number
NCT00790751
Locations
🇺🇸

Research Site, Spring, Texas, United States

To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of Avanafil

First Posted Date
2008-10-09
Last Posted Date
2009-12-02
Lead Sponsor
VIVUS LLC
Target Recruit Count
44
Registration Number
NCT00770042
Locations
🇺🇸

Research Site, Lincoln, Nebraska, United States

A Thorough EKG Safety Study of TA-1790 (Avanafil)

First Posted Date
2008-10-08
Last Posted Date
2011-01-07
Lead Sponsor
VIVUS LLC
Target Recruit Count
57
Registration Number
NCT00769041
Locations
🇺🇸

Covance Phase 1 Clinical Unit, Madison, Wisconsin, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy